Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. - Wikidata - thesis-toulmin - TriplyDB

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

http://www.wikidata.org/entity/Q37955871

about

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy Psychosocial Modulators of Motor Learning in Parkinson's Disease Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Parkinson's disease as a result of aging Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis A loss of Pdxk model of Parkinson disease in Drosophila can be suppressed by Buffy Auditory- and Vestibular-Evoked Potentials Correlate with Motor and Non-Motor Features of Parkinson's Disease.Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease Embryonic development of selectively vulnerable neurons in Parkinson's disease.Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal study Genetic factors and manganese-induced neurotoxicity.Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.The regulation of catalase activity by PPAR γ is affected by α-synuclein.Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease.Dopaminergic therapy affects learning and impulsivity in Parkinson's disease.A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra.Hypothesis: somatic mosaicism and Parkinson disease Changes of retina are not involved in the genesis of visual hallucinations in Parkinson's disease.Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease.Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.Parkinson disease and incidental Lewy body disease: Just a question of time?Increased Risk of Parkinson's Disease in Patients With Obstructive Sleep Apnea: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study.Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra.High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction.α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

P2860

Q24338188-DF765D91-2EB8-4788-965B-ADF61E136D74 Q26766021-E3E50051-532D-462B-9DB1-66780D09DCD8 Q26768648-8C9D0349-917C-4940-90D8-420612CDE18D Q26773064-E5293C27-89DB-418C-9BE9-CA6FC1AC3BAB Q26795984-7B0B4F1A-9889-4D9E-A56C-BB9EDF1CE373 Q26801733-DB49493A-4F4C-4279-9BB1-4ABEF6268F12 Q27004240-65384D9B-9504-4FF3-9654-5EB0C3B02C69 Q27322513-02D28D61-A959-4C96-A05E-534875C7CD56 Q28084395-9C19D089-85DB-419D-A32A-AF82537DD42E Q28272173-3D72779A-9CCA-4826-8588-97CC3BFCD1CA Q28384572-9FDC2947-F63B-44F6-84D8-ECA35AF6DF15 Q30352332-607AE475-05E0-44B8-A6C1-02112469B31F Q30361239-67ED9231-2AE4-434D-95C4-49B7CDF971F1 Q30573776-EB1DB168-778B-4EE7-B806-523CDF260A25 Q30577415-33D5827B-D40F-4191-BCE5-96F887E3F92C Q30626337-7BCD7FB8-E044-4805-9147-10B866CCDE50 Q30859509-6254F515-AA36-4211-BB06-A1DED48889AD Q31105385-24D463A3-93BE-4026-8CA7-6519A04E5CB3 Q33624586-3FB76F0D-A245-4C58-9766-F0B776C90BB0 Q33814277-21D077D2-4987-4B13-A213-D51E5A5B49F8 Q33835242-142E2BEF-1151-4202-AD62-44794B36FA7D Q33917294-AD257911-866C-45E6-BD90-F8A9FAB6F050 Q33997453-42542A11-2F4F-4C74-B4D3-ABA02B670ECF Q34239492-D8ED9A11-1220-480F-AB81-4E9FF1F2A3E2 Q34286365-343E21C2-318C-4700-AFD6-A3ECD4392FF8 Q34299923-33A30989-80A1-43D2-886D-C04EF5C37B5A Q34401518-0058D3A7-0B13-48B5-9DE2-FF6F5F1C2A3E Q34562882-417277EE-1F24-432C-808C-D8F9BFB4C046 Q34611889-A61599E4-5A0F-4D29-934A-FF3FC12FF609 Q34679823-A7F21E07-C40C-4D97-8FA6-B3864F2355FE Q34774314-13CB8C29-D1EE-4FB3-AD57-29036C32C819 Q35097665-F65E8E04-DC9D-4A6F-AEFF-C99D8A4DB8FD Q35139572-70031634-5C81-4AE8-8465-0D304C0A858B Q36104787-46DD8336-9BD5-4CBB-9387-43FD4E839657 Q36271380-E0FC9719-66A2-43D3-8931-59A8255F11D4 Q36300086-EFA04FE9-762C-43E8-9985-08D3C32C5D1B Q36478030-7D4DF0A2-26B3-4B0F-9C25-936F849CD8A4 Q36639486-579FE033-05D2-4A71-A206-2B0B9A7B7B3E Q36748956-BE2AF56C-4335-4F67-84FA-560BF344DC14 Q36925651-0E7EE0DC-0B91-4E9F-86D5-F5FF5C354E7B

P2860

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

http://www.wikidata.org/entity/Q37955871

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

@en

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

@nl

type

label

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

@en

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

@nl

prefLabel

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

@en

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

@nl

P1433

Q37955871-2FB44BDB-7B2E-4F13-926A-D81B55BC6918

P1476

Q37955871-8EFF0C00-3467-4D61-A1A9-36AC4294D605

P2093

Q37955871-6D4AEC65-29F0-4DC6-B194-0D56DF0CB56F

P2860

Q37955871-0004C484-9E22-4918-8841-1747CDACB220

Q37955871-01ACD00C-C800-46FD-9C62-1B4A6AE040AC

Q37955871-02D7CDA0-AE62-4345-BAA2-3F64BF6E11BD

Q37955871-03893884-C1A1-4AA8-AF4F-9327903715E4

Q37955871-03958275-EAAD-4380-A98B-13475620AEB5

Q37955871-044239B0-CF4F-4813-B6BB-CB37631C4C51

Q37955871-04B80F81-3C2F-43EB-8404-A7D90121D46F

Q37955871-051D95AF-459B-4E9A-904D-FCA6041111A4

Q37955871-05A8145F-9C00-4934-B15A-479D9ACC4277

Q37955871-07839EF9-5EC6-4539-A554-E99500A645DB

P304

Q37955871-1CFB80B1-39A7-410D-B63C-FEE465254BED

P31

Q37955871-90B3A9D9-2590-49BF-8B83-B856E528F41B

P356

Q37955871-8B203BFB-CEAF-4C2A-AD59-B05FEC7BA85C

P407

Q37955871-555FCB43-049B-43ED-AFEA-36CBE522EEA9

P433

Q37955871-799B20DD-BD45-46FD-AAF5-476692A6DED6

P478

Q37955871-6B188E73-FECE-475D-BEE9-10D0CDC34FB6

P577

Q37955871-FA69529B-8AF0-43C0-BC72-C988B3817E0B

P698

Q37955871-1E05AE39-C96D-463A-A023-ED08FC0B1BD1

P921

Q37955871-89A91C70-BD2E-48E1-A9E1-552671FF91ED

P356

P1433

Movement Disorders

P1476

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

@en

P2093

Kurt A Jellinger

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's disease: clinical features and diagnosis

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples

Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro

Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies

Molecular motors implicated in the axonal transport of tau and alpha-synuclein

Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

Alpha-synuclein in Lewy bodies

Staging of brain pathology related to sporadic Parkinson's disease

P304

8-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23795

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22081500

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease